Biswasjit Das
4PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 09, 2025
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.Anne S Tsao, Zihe Song, Alan L Ho
|Jul 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).Matthew Ingham, Jacob B Allred, Li Chen
|Oct 28, 2021
An Anti-inflammatory Fe3 O4 -Porphyrin Nanohybrid Capable of Apoptosis through Upregulation of p21 Kinase Inhibitor Having Immunoprotective Properties under Anticancer PDT Conditions.Devashish Sengupta, Subhojit Das, Debdulal Sharma
|Apr 17, 2021
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors.Naoko Takebe, Abdul Rafeh Naqash, Geraldine O'Sullivan Coyne
Pageof 1
Frequent Collaborators
2 joint publications
Naoko Takebe
2 joint publications
Larry V Rubinstein
1 joint publications
Abdul Rafeh Naqash
1 joint publications
Geraldine O'Sullivan Coyne
1 joint publications
Richard Piekarz
1 joint publications
Elad Sharon
1 joint publications
James H Doroshow
1 joint publications
Alice P Chen
1 joint publications
Devashish Sengupta
1 joint publications
Subhojit Das
